Stereotactic biopsy suit heats up

Article

Lorad Medical Systems and Fischer Imaging wielded charges andcountercharges last week during pretrial procedures for Fischer'sstereotactic-guided biopsy patent infringement suit (SCAN 4/8/92). Lorad fired the first public shot with release of a

Lorad Medical Systems and Fischer Imaging wielded charges andcountercharges last week during pretrial procedures for Fischer'sstereotactic-guided biopsy patent infringement suit (SCAN 4/8/92).

Lorad fired the first public shot with release of a statementthat Fischer Imaging has dropped two more of its patent claimsfiled against Lorad. Only two claims remain, down from the 16originally filed in April, Lorad said.

Withdrawing its patent claims one at a time is a way of droppingthe suit while saving face, according to Lorad.

"It's only a matter of time before this case is dismissed,"said Hal Kirshner, Lorad president.

Fischer countered with its own public statement discountingthe importance of the reduced number of claims. Narrowing thenumber of claims is common practice in patent suits as informationis reviewed during the discovery period, said Robert A. Cascella,executive vice president and CFO of Fischer.

Fischer initially cited five interrelated claims against Loradin its suit and reduced this to the two primary claims after reviewingLorad technical documentation, he said. These two claims, regardingelements of prone positioning, the stereotactic guided arm anddigital processing, had always been the essence of the patents,he said.

Lorad has made other claims about Fischer's image quality thatare not substantiated by comparative testing of the two systems,according to the Fischer statement. The company is consideringadditional nonpatent litigation against Lorad related to theseproduct claims, the company said.

Recent Videos
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
Related Content
© 2025 MJH Life Sciences

All rights reserved.